Page 3 - Cold Syrup News Today

The development comes on a day the Haryana government ordered the halting of drug manufacturing at the Sonipat unit of Maiden Pharmaceuticals, and asked it to explain within a week "many contraventions" found during a recent inspection, or face suspension or cancellation of license.

The Central Government on Wednesday formed a four-member expert committee to investigate the report sent by the World Health Organisation (WHO) on the deaths of

The World Health Organisation (WHO), which recently issued a medical health alert against cough syrups manufactured by Indian firm Maiden Pharmaceuticals following the death of 66 children in Gambia, on October 29 informed the Drug Controller General of India (DGCI) that it collected 23 samples of medicines under reference for further testing and four samples were found to be contaminated with diethylene glycol/ ethylene glycol--an ingredient which may have contributed to the death of the childr...

New Delhi, Oct. 12 (PTI): The government on Wednesday formed a four-member panel of experts to examine the details and adverse event reports received from the WHO on the deaths of 66 children in The Gambia being linked potentially to the four made-in-India cough syrups, official sources here said. They said after examining and analysing the adverse event reports, causal relationship and all related details shared by or to be shared by the World Health Organization, the committee will advise and ...

The company has manufactured and exported these products only to Gambia

The Central Government on Wednesday formed a four-member expert committee to investigate the report sent by the World Health Organisation (WHO) on the deaths of

The suspension of membership implies that Maiden Pharmaceuticals will not be eligible to receive any incentives.

Central Drugs Standard Control Organisation (CDSCO) launched an inquiry and alerted Haryana last week after learning about the Gambia tragedy.

After the World Health Organization (WHO) warned that it suspected four cough syrups could be linked to the deaths of 66 children in Gambia, the Delhi-based manufacturer, Maiden Pharmaceuticals, is in the news. The syrups, the WHO said, have been “potentially linked with acute kidney injuries and 66 deaths among children.” The global body also

Following the WHO’s warning, the centre is looking into four cough syrups that may be responsible for at least 66 child deaths in The Gambia. India has already been under fire for exporting fake and substandard medications, but it also has a similar issue at home. Indian-made cough syrups are being investigated in connection with